UNITY Biotechn…
ProfileJobs

UNITY Biotechnology

Suggest Edit
    • Healthbiotechpharmatherapy
    Unity Biotechnology, Inc. designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.
    Market capitalization(2018-05-25)
    $544.7 M
    Type
    Public
    HQ
    San Francisco, US
    Founded
    2009
    Size (employees)
    7 (est)
    Website
    unitybiotechnology.com
    UNITY Biotechnology was founded in 2009 and is headquartered in San Francisco, US
    Report incorrect company information

    Key People/Management at UNITY Biotechnology

    M.s. Keith R. Leonard

    M.s. Keith R. Leonard

    Chief Executive Officer
    Bob Goeltz

    Bob Goeltz

    Chief Financial Officer
    Nathaniel David

    Nathaniel David

    President
    Jamie Dananberg

    Jamie Dananberg

    Chief Medical Officer
    D. Dan Marquess

    D. Dan Marquess

    Chief Scientific Officer
    Tamara Tompkins

    Tamara Tompkins

    General Counsel
    Show more

    UNITY Biotechnology Office Locations

    UNITY Biotechnology has an office in San Francisco
    Show all (1)
    Report incorrect company information

    UNITY Biotechnology Financials and Metrics

    UNITY Biotechnology Financials

    Market capitalization (25-May-2018)

    		544.7 m

    Closing share price (25-May-2018)

    		13
    UNITY Biotechnology's current market capitalization is $544.7 m.
    Show all financial metrics
    Report incorrect company information

    Competitors

    Cellestia Biotech
    Health - Private
    Hedgepath Pharmaceuticals
    Health - Public
    Alexion Pharmaceuticals
    Health - Public
    Bellerophon Therapeutics
    Health - Public
    Compare competitors
    Download PDF